انتقل إلى المحتوى
لرعاية هذه الصفحة تواصل معنا ←
الجمعة السوداء: اخترنا لكم أجمل الهدايا والعطورتصفّح الهدايا

أدوية ومنتجات صحية

Cyclophosphamide for Injection USP: Presence of particulate matter

تفاصيل الاستدعاء أدناه منشورة بالإنجليزية كما أصدرتها الحكومة الكندية دون تعديل. لم تنشر الحكومة صوراً لهذا المنتج.

Summary

TypeHealth product recall
ProductCyclophosphamide for Injection USP
IssueHealth products - Product quality
What to do

Consult your healthcare provider for any health concerns. 

DistributionNational
Last updated2026-10-30

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot Number

Marcan Pharmaceuticals Inc

Cyclophosphamide for Injection USP

DIN 02560216

Powder for Solution

1000 mg/vial

7Z10346A

Issue

Presence of particulate matter in affected lot.

What you should do

  1. Consult your healthcare provider for any health concerns.
  2. Contact the recalling firm if you have any questions about the recall.
  3. Report any health product related side effects to Health Canada.
  4. Report any other health product safety complaints to Health Canada.

Background

Depth of recall: Healthcare establishments

Details

Original published date2026-11-02
Alert / recall typeHealth product recall
CategoryHealth products - Drugs
Companies

Marcan Pharmaceuticals Inc  

2 Gurdwara Rd. Suite #400, 

Ottawa, ON

K2E 1A2

Published byHealth Canada
AudienceGeneral public
Healthcare
Industry
DistributionNational
Recall classType I
Identification numberRA-82896

Source: Government of Canada, Recalls and safety alerts – https://recalls-rappels.canada.ca/en/alert-recall/cyclophosphamide-injection-usp-presence-particulate-matter

خدمات أخرى من هلا كندا